We use cookies to ensure that we give you the best experience on our website. If you continue browsing our
website without changing your settings, we will assume that you are happy to receive all cookies on our site.

You can visit our Cookie Policy page to learn more about cookies and how to disable them, should you wish to withdraw your consent. Our Cookie Policy page explains what cookies are, lists the cookies used on this website, and outlines how you can manage them.

Continue
 
Subscribe to our regular email newsletter

Before you go...

Please give us your feedback on our site:

How useful was the site to
you today?


WHO analgesic ladder

The Cancer Pain Relief Programme of the WHO advocates a three-step ‘analgesic ladder’ in an attempt to improve the worldwide management of pain due to cancer (Figure 1).1

Figure 1. WHO analgesic ladder for cancer pain

The WHO pain ladder is a framework for providing symptomatic pain relief. The three-step approach is inexpensive and 70–90% effective1–4

By mouth

The oral route is preferred for all steps of the pain ladder1,2

By the clock

Cancer pain is continuous - analgesics should be given at regular intervals (every three to six hours), not on demand1

Adjuvants

To help calm fears and anxiety, adjuvant drugs may be added at any step of the ladder

 who-analgesic-ladder-cancer-pain


    The underlying principle is that, following good pain assessment and thorough knowledge of a small number of analgesics, a simple approach should produce pain relief in the majority of patients.2 In essence, the approach combines two modalities of pain relief:1

    1. Non-opioid analgesics, such as NSAIDs or paracetamol, reduce inflammation and/or prostaglandin synthesis and thereby reduce nociceptive stimuli.
    2. Opioids reduce nociceptive transmission through inhibition at opioid receptors in the brainstem, spinal cord and perhaps peripheral nerves.

    Opioids for mild-to-moderate pain are used in combination with a non-opioid analgesic, such as paracetamol, at the second step of the ladder. There are numerous combination step 2 analgesics available, however combinations may increase side-effects yet may not significantly increase efficacy.5

    If regular maximum doses of opioids for mild-to-moderate pain do not achieve adequate analgesia, then they should be replaced with an opioid for moderate-to-severe pain, such as morphine.1

    There is some debate as to whether the second step of the ladder adds value.2,4

    One might argue it would make sense to simply add very small doses of strong opioids to non-opioids (for example, morphine 2.5mg). The added value of step 2 probably lies in the availability of these drugs worldwide rather than in superiority of effect.4 In moderate pain it is perfectly reasonable to commence small doses of strong opioids (licensed for moderate pain) without recourse to the ‘weaker’ opioids first.4,6

    Although the WHO analgesic ladder was developed for use in cancer pain, a stepwise approach is probably equally applicable to the management of chronic pain due to other causes.2


    References

    1. WHO Pain Relief Ladder for cancer pain relief. Available at: www.who.int/cancer/palliative/painladder/en/ (accessed 14 April 2015).
    2. Vargas-Schaffer G. Canadian Family Physician 2010;56(6):514–517, e202–205.
    3. Azevedo São Leão Ferreira K, Kimura M, et al. Supportive Care in Cancer 2006;14(11):1086–1093.
    4. Eisenberg E, Marinangeli F, et al. Time to Modify the WHO Analgesic Ladder? Pain: Clinical Updates 2005;13(5):1–4.
    5. British National Formulary online March 2015. Available at: www.evidence.nhs.uk/formulary/bnf/current/4-central-nervous-system/47-analgesics/471-non-opioid-analgesics-and-compound-analgesic-preparations/compound-analgesic-preparations (accessed 14 April 2015).
    6. Maltoni M, Scarpi E, et al. Supportive Care in Cancer 2005;13(11): 888–894.

     




    Date of preparation: September 2015; MINT/PAEU-14003